Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nam Kim and Myoung-Don Oh.
Nam Kim
Connection Strength
10.208
Myoung-Don Oh
  1. A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms. Korean J Intern Med. 2020 07; 35(4):758-764.
    View in: PubMed
    Score: 0.887
  2. Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med. 2018 03; 33(2):233-246.
    View in: PubMed
    Score: 0.757
  3. Viral Load Kinetics of MERS Coronavirus Infection. N Engl J Med. 2016 Sep 29; 375(13):1303-5.
    View in: PubMed
    Score: 0.686
  4. Middle East Respiratory Syndrome Coronavirus Superspreading Event Involving 81 Persons, Korea 2015. J Korean Med Sci. 2015 Nov; 30(11):1701-5.
    View in: PubMed
    Score: 0.642
  5. Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection. J Infect Dis. 2021 09 17; 224(6):1097-1099.
    View in: PubMed
    Score: 0.242
  6. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 07 02; 224(1):39-48.
    View in: PubMed
    Score: 0.239
  7. Antibody Responses One Year after Mild SARS-CoV-2 Infection. J Korean Med Sci. 2021 May 31; 36(21):e157.
    View in: PubMed
    Score: 0.237
  8. Can reactogenicity predict immunogenicity after COVID-19 vaccination? Korean J Intern Med. 2021 11; 36(6):1486-1491.
    View in: PubMed
    Score: 0.237
  9. Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection. J Korean Med Sci. 2021 Apr 12; 36(14):e101.
    View in: PubMed
    Score: 0.235
  10. Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection. Emerg Infect Dis. 2021 03; 27(3):928-931.
    View in: PubMed
    Score: 0.230
  11. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection. Emerg Infect Dis. 2021 01; 27(1).
    View in: PubMed
    Score: 0.227
  12. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerg Infect Dis. 2020 10; 26(10):2484-2487.
    View in: PubMed
    Score: 0.222
  13. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. J Korean Med Sci. 2020 Jun 22; 35(24):e231.
    View in: PubMed
    Score: 0.222
  14. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020 Aug; 97:313-321.
    View in: PubMed
    Score: 0.221
  15. Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea. Korean J Intern Med. 2020 07; 35(4):765-770.
    View in: PubMed
    Score: 0.221
  16. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J Intern Med. 2020 07; 35(4):782-787.
    View in: PubMed
    Score: 0.221
  17. Virus Isolation from the First Patient with SARS-CoV-2 in Korea. J Korean Med Sci. 2020 Feb 24; 35(7):e84.
    View in: PubMed
    Score: 0.217
  18. Prospective evaluation of a rapid antimicrobial susceptibility test (QMAC-dRAST) for selecting optimal targeted antibiotics in positive blood culture. J Antimicrob Chemother. 2019 08 01; 74(8):2255-2260.
    View in: PubMed
    Score: 0.209
  19. Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study. Vaccine. 2019 06 27; 37(29):3820-3824.
    View in: PubMed
    Score: 0.206
  20. An Atypical Case of Middle East Respiratory Syndrome in a Returning Traveler to Korea from Kuwait, 2018. J Korean Med Sci. 2018 Dec 31; 33(53):e348.
    View in: PubMed
    Score: 0.200
  21. Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine. Infect Chemother. 2018 Dec; 50(4):311-318.
    View in: PubMed
    Score: 0.199
  22. The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension. Antimicrob Agents Chemother. 2018 07; 62(7).
    View in: PubMed
    Score: 0.193
  23. Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection. Int J Infect Dis. 2018 Jul; 72:8-10.
    View in: PubMed
    Score: 0.192
  24. Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence. BMC Infect Dis. 2018 04 16; 18(1):178.
    View in: PubMed
    Score: 0.191
  25. 18F-FDG PET and histopathologic findings in a patient with severe fever with thrombocytopenia syndrome. Ticks Tick Borne Dis. 2018 05; 9(4):972-975.
    View in: PubMed
    Score: 0.190
  26. Sudden Deaths of Neonates Receiving Intravenous Infusion of Lipid Emulsion Contaminated with Citrobacter freundii. J Korean Med Sci. 2018 Mar 05; 33(10):e97.
    View in: PubMed
    Score: 0.189
  27. Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies. Ther Drug Monit. 2018 02; 40(1):115-119.
    View in: PubMed
    Score: 0.188
  28. Direct rapid antibiotic susceptibility test (dRAST) for blood culture and its potential usefulness in clinical practice. J Med Microbiol. 2018 Mar; 67(3):325-331.
    View in: PubMed
    Score: 0.188
  29. Epidemiology and Clinical Characteristics of Zika Virus Infections Imported into Korea from March to October 2016. J Korean Med Sci. 2017 Sep; 32(9):1440-1444.
    View in: PubMed
    Score: 0.183
  30. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Emerg Infect Dis. 2017 07; 23(7):1079-1084.
    View in: PubMed
    Score: 0.181
  31. Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies. Infect Chemother. 2017 Jun; 49(2):135-139.
    View in: PubMed
    Score: 0.180
  32. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis. Int J STD AIDS. 2017 12; 28(14):1426-1432.
    View in: PubMed
    Score: 0.180
  33. Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. J Korean Med Sci. 2017 May; 32(5):744-749.
    View in: PubMed
    Score: 0.179
  34. Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection. J Korean Med Sci. 2016 Nov; 31(11):1717-1725.
    View in: PubMed
    Score: 0.173
  35. Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak. J Korean Med Sci. 2016 Feb; 31(2):315-20.
    View in: PubMed
    Score: 0.163
  36. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis. 2015 Dec; 21(12):2186-9.
    View in: PubMed
    Score: 0.162
  37. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 2015; 20(41).
    View in: PubMed
    Score: 0.152
  38. Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Sci Transl Med. 2021 01 27; 13(578).
    View in: PubMed
    Score: 0.058
  39. Communication: Comparison of Respiratory Specimens for the Detection of SARS-CoV-2. Ann Clin Lab Sci. 2021 Jan; 51(1):140-144.
    View in: PubMed
    Score: 0.058
  40. Compassionate use of hzVSF-v13 in two patients with severe COVID-19. J Med Virol. 2020 11; 92(11):2371-2373.
    View in: PubMed
    Score: 0.055
  41. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. J Korean Med Sci. 2020 Apr 06; 35(13):e142.
    View in: PubMed
    Score: 0.055
  42. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections. Emerg Infect Dis. 2019 10; 25(10):1868-1877.
    View in: PubMed
    Score: 0.053
  43. Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species. J Korean Med Sci. 2019 Apr 15; 34(14):e116.
    View in: PubMed
    Score: 0.051
  44. Delayed diagnosis of extrapulmonary tuberculosis presenting as fever of unknown origin in an intermediate-burden country. BMC Infect Dis. 2018 Aug 28; 18(1):426.
    View in: PubMed
    Score: 0.049
  45. Risk factors for poor outcome in community-onset Clostridium difficile infection. Antimicrob Resist Infect Control. 2018; 7:75.
    View in: PubMed
    Score: 0.048
  46. Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome. J Korean Med Sci. 2018 Jun 11; 33(24):e169.
    View in: PubMed
    Score: 0.048
  47. The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study. Blood Res. 2017 Dec; 52(4):300-306.
    View in: PubMed
    Score: 0.047
  48. Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years. Int J Hematol. 2017 Dec; 106(6):801-810.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.